These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 32911014)

  • 21. Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities.
    Chen YC; Gad SF; Chobisa D; Li Y; Yeo Y
    J Control Release; 2021 Feb; 330():438-460. PubMed ID: 33352244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioresponsive drug delivery systems.
    Alavi SE; Alharthi S; Alavi SZ; Raza A; Ebrahimi Shahmabadi H
    Drug Discov Today; 2024 Jan; 29(1):103849. PubMed ID: 38052319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment.
    Wang CJ; Byun MJ; Kim SN; Park W; Park HH; Kim TH; Lee JS; Park CG
    J Control Release; 2022 May; 345():1-19. PubMed ID: 35227764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective Oxidation-Responsive Polyester Nanocarriers for Anti-Inflammatory Drug Delivery.
    He P; Tang B; Li Y; Zhang Y; Liu X; Guo X; Wang D; She P; Xiao C
    Int J Nanomedicine; 2021; 16():5053-5064. PubMed ID: 34349508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineered bioresponsive nanotherapeutics: recent advances in the treatment of atherosclerosis and ischemic-related disease.
    Rumanti AP; Maruf A; Liu H; Ge S; Lei D; Wang G
    J Mater Chem B; 2021 Jun; 9(24):4804-4825. PubMed ID: 34085084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral hydrogel nanoemulsion co-delivery system treats inflammatory bowel disease via anti-inflammatory and promoting intestinal mucosa repair.
    Lei F; Zeng F; Yu X; Deng Y; Zhang Z; Xu M; Ding N; Tian J; Li C
    J Nanobiotechnology; 2023 Aug; 21(1):275. PubMed ID: 37596598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoparticles for the regulation of intestinal inflammation: opportunities and challenges.
    Nunes R; Neves JD; Sarmento B
    Nanomedicine (Lond); 2019 Oct; 14(19):2631-2644. PubMed ID: 31612773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pH/ROS dual-responsive and targeting nanotherapy for vascular inflammatory diseases.
    Zhang R; Liu R; Liu C; Pan L; Qi Y; Cheng J; Guo J; Jia Y; Ding J; Zhang J; Hu H
    Biomaterials; 2020 Feb; 230():119605. PubMed ID: 31740099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue.
    Hua S; Marks E; Schneider JJ; Keely S
    Nanomedicine; 2015 Jul; 11(5):1117-32. PubMed ID: 25784453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug targeting systems for inflammatory disease: one for all, all for one.
    Crielaard BJ; Lammers T; Schiffelers RM; Storm G
    J Control Release; 2012 Jul; 161(2):225-34. PubMed ID: 22226771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel drug delivery systems for inflammatory bowel disease.
    Yasmin F; Najeeb H; Shaikh S; Hasanain M; Naeem U; Moeed A; Koritala T; Hasan S; Surani S
    World J Gastroenterol; 2022 May; 28(18):1922-1933. PubMed ID: 35664964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhalable, bioresponsive microparticles for targeted drug delivery in the lungs.
    Sivadas N; Cryan SA
    J Pharm Pharmacol; 2011 Mar; 63(3):369-75. PubMed ID: 21749384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smart stimuli-responsive hydrogels for drug delivery in periodontitis treatment.
    Wang Y; Li J; Tang M; Peng C; Wang G; Wang J; Wang X; Chang X; Guo J; Gui S
    Biomed Pharmacother; 2023 Jun; 162():114688. PubMed ID: 37068334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral delivery of folate-targeted resveratrol-loaded nanoparticles for inflammatory bowel disease therapy in rats.
    Naserifar M; Hosseinzadeh H; Abnous K; Mohammadi M; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2020 Dec; 262():118555. PubMed ID: 33035579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Dual-Bioresponsive Drug-Delivery Depot for Combination of Epigenetic Modulation and Immune Checkpoint Blockade.
    Ruan H; Hu Q; Wen D; Chen Q; Chen G; Lu Y; Wang J; Cheng H; Lu W; Gu Z
    Adv Mater; 2019 Apr; 31(17):e1806957. PubMed ID: 30856290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease.
    Li DF; Yang MF; Xu HM; Zhu MZ; Zhang Y; Tian CM; Nie YQ; Wang JY; Liang YJ; Yao J; Wang LS
    J Mater Chem B; 2022 Aug; 10(31):5853-5872. PubMed ID: 35876136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
    Shrestha N; Xu Y; Prévost JRC; McCartney F; Brayden D; Frédérick R; Beloqui A; Préat V
    Acta Biomater; 2022 Mar; 140():561-572. PubMed ID: 34923097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and characterization of an injectable microparticles integrated hydrogel composite biomaterial: In-vivo biocompatibility and inflammatory arthritis treatment.
    Dhanka M; Pawar V; Chauhan DS; Jain NK; R S P; Shetty C; Kumawat MK; Prasad R; Srivastava R
    Colloids Surf B Biointerfaces; 2021 May; 201():111597. PubMed ID: 33609936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptors: promising therapeutic targets for inflammatory diseases.
    Achek A; Yesudhas D; Choi S
    Arch Pharm Res; 2016 Aug; 39(8):1032-49. PubMed ID: 27515048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease.
    Lamprecht A; Ubrich N; Yamamoto H; Schäfer U; Takeuchi H; Maincent P; Kawashima Y; Lehr CM
    J Pharmacol Exp Ther; 2001 Nov; 299(2):775-81. PubMed ID: 11602694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.